GlaxoSmithKline (LSE:GSK)
GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
{{ formattedPrice }} {{ change }} (0.68%)
Quotes delayed. Last trade: 26-04-2018, 12:54:55pm BST
| Open Price | {{ openPrice }} | Close Price | {{ closePrice }} |
| Day High | {{ high }} | Day Low | {{ low }} |
| Bid | {{ bid }} | Ask | {{ ask }} |
| Volume | 3269803 |
Related Articles
-
GlaxoSmithKline’s share price and 5% dividend yield make it my buy of the decade
Harvey Jones says the combination of a cut price valuation and 5% plus yield make GlaxoSmithKline plc (LON: GSK) a rare opportunity for long-term... Read More »
-
Why GlaxoSmithKline’s share price could be about to skyrocket
A 5%+ yield, double-digit profit growth, improving balance sheet and dirt-cheap valuation put GlaxoSmithKline plc (LON: GSK) in a fantastic position. Read More »
-
GlaxoSmithKline’s share price is rising. Is it time to buy?
GlaxoSmithKline plc's (LON: GSK) share price has bounced 10% in the last few weeks. Is now the time to take a closer look at... Read More »
-
Why I believe the GlaxoSmithKline share price is now too cheap to ignore
I believe the GlaxoSmithKline plc (LON: GSK) share price can only go up from here. Read More »
-
GlaxoSmithKline plc isn’t the only pharma stock I’d buy today
Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn't the only pharma star that could make you a fortune. Read More »
-
Top shares for April
We asked our analysts to share their top stock picks for the month. Read More »
-
Why I’d buy 6% yielder GlaxoSmithKline plc for my ISA after this news
A new deal has lifted the GlaxoSmithKline plc (LON:GSK) share price. Roland Head explains why he'd rate the stock as a buy. Read More »
-
GlaxoSmithKline plc isn’t the only pharma stock worth investing in for retirement
This company could generate high returns alongside GlaxoSmithKline plc (LON:GSK) (GSK.L). Read More »
-
Is Footsie dividend stalwart GlaxoSmithKline plc’s dividend under threat?
Here's why recent positive numbers from pharma giant GlaxoSmithKline plc (LON:GSK) may not be enough to prevent it from cutting its prized dividend. Read More »
-
Why I’d buy and hold dividend stocks GlaxoSmithKline plc & Taylor Wimpey plc
GlaxoSmithKline plc (LON: GSK) and Taylor Wimpey plc (LON: TW) could be among the best dividend payers of the next decade. Read More »